Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-061604
Filing Date
2008-11-19
Accepted
2008-11-19 16:37:02
Documents
1
Period of Report
2008-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9164
  Complete submission text file 0001209191-08-061604.txt   11057
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Issuer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address BARR LABORATORIES INC 300 CORPORATE DRIVE SUITE 10 BLAUVELT NY 10913 18002275227
MUNDKUR CHRISTINE (Reporting) CIK: 0001237264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09860 | Film No.: 081201391